At the national level, a decreasing trend in ASDR of CKD attributed to HFPG was observed in 81 countries, primarily located in regions with higher SDI, such as Eastern Europe.
← all excerpts
Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
1
—
—